KRISTEN SPENCER: Open Payments
NPI 1255721700 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,600 in 136 payments from 19 companies in 2025. Trend: 2023 $1,477 · 2024 $1,670 · 2025 $2,600
Food & beverage: $2,600
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $610 |
| PFIZER INC. | 16 | $316 |
| Janssen Biotech, Inc. | 10 | $290 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $282 |
| Regeneron Healthcare Solutions, Inc. | 7 | $185 |
| Ipsen Biopharmaceuticals, Inc | 10 | $175 |
| Lilly USA, LLC | 7 | $170 |
| Aimmune Therapeutics, Inc. | 7 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $117 |
| GENZYME CORPORATION | 5 | $90 |
Products named: RINVOQ, DUPIXENT, TREMFYA, ENTYVIO, VELSIPITY, IQIRVO, OMVOH, XELJANZ.
Industry payments across KY — which companies pay providers there.
